What is the price of a bottle of pomalidomide 4mg?

Pomalidomide (Pomalidomide) is an important immunomodulatory anti-cancer drug, mainly used to treat relapsed and refractory multiple myeloma. With the improvement of domestic medical standards, pomalidomide has been officially launched in China and has been included in the national medical insurance directory, which has brought patients more convenient medication access and certain financial support. Its common specification is 4mg in one bottle, which is convenient for patients to carry out personalized treatment according to the doctor's prescription.

Although pomalidomide has been included in medical insurance, the price is still relatively high because it is an innovative anti-cancer drug. The specific selling price of a bottle of 4mg pomalidomide in the domestic market will vary depending on the region and hospital, and is generally more expensive. When purchasing, it is recommended that patients first consult the local hospital pharmacy to understand the actual payment amount after medical insurance reimbursement, so as to reasonably arrange treatment costs and reduce the financial burden.

In addition to the domestic original drug, there are also generic versions of pomalidomide on the foreign market. The price of generic drugs produced in countries such as Laos is significantly lower than that of domestic original drugs, and the price is about more than 300 yuan. This lower-priced generic drug provides an affordable option for some patients, but patients should confirm the formality and safety of the drug source before using it to ensure the therapeutic effect and medication safety.

Overall, pomalidomide, as an important drug for the treatment of multiple myeloma, has been launched in China and is included in medical insurance, making it more convenient for patients to purchase drugs. Although the price is still high, the support of medical insurance has effectively alleviated part of the burden. At the same time, the emergence of low-priced generic drugs abroad has also brought more choices to patients. It is recommended that patients use drugs rationally under the guidance of doctors and choose appropriate drug purchase channels based on their own economic conditions to ensure the continuity and effect of treatment.

Reference materials:https://www.drugs.com/